Diagnosis and Evaluation of Bronchiectasis.


Journal

Clinics in chest medicine
ISSN: 1557-8216
Titre abrégé: Clin Chest Med
Pays: United States
ID NLM: 7907612

Informations de publication

Date de publication:
03 2022
Historique:
entrez: 3 3 2022
pubmed: 4 3 2022
medline: 6 5 2022
Statut: ppublish

Résumé

Bronchiectasis is characterized by inflammation and abnormal dilatation of the airways secondary to various etiologies. A diagnosis of bronchiectasis requires that both radiological and clinical features are present. Determination of the etiology of bronchiectasis is important to allow specific treatment and should be guided by clinical features. The prognosis of bronchiectasis is highly variable, with severe cases suffering frequent exacerbations and hospitalizations, debilitating symptoms, and elevated mortality. Treatment is demanding, but adherence to treatment is associated with improved outcomes and should be assessed and reinforced. A partnership between patients and health care professionals is key to successful outcomes.

Identifiants

pubmed: 35236562
pii: S0272-5231(21)01239-9
doi: 10.1016/j.ccm.2021.11.001
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-22

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure Dr M. Shteinberg has received research grants from Novartis, Israel; Trudell pharma, Canada; GSK- Israel; travel grants from Novartis, Actelion, Boeringer Ingelheim, GSK, Rafa; speaker's fees from Boeringer Ingelheim, GSK, Astra Zeneca, Teva, Novartis, Kamada; and advisory fees from GSK, Boeringer Ingelheim, Zambon, Vertex pharmaceuticals. Dr M. Shteinberg is a member of the EMBARC group management. Dr R. Cohen has nothing to disclose.

Auteurs

Raya Cohen (R)

Pulmonology Institute and CF Center, Carmel Medical Center, Technion- Israel Institute of Technology, The B. Rappaport Faculty of Medicine, 7 Michal Street, Haifa 3436212, Israel.

Michal Shteinberg (M)

Pulmonology Institute and CF Center, Carmel Medical Center, Technion- Israel Institute of Technology, The B. Rappaport Faculty of Medicine, 7 Michal Street, Haifa 3436212, Israel. Electronic address: michalsh@technion.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH